Sera Prognostics, Inc. (SERA) stock
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
$1.91−0.09 (-4.50%)
Close on Nov 18, 2026Market cap $75.35MP/E –Yield –
Sera Prognostics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Sera Prognostics's gross profit for the twelve months ending Jun 30, 2026 was -$105.00K. For fiscal 2025 it was -$83.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$83.00K | – |
| FY2024 | Dec 31, 2024 | -$5.00K | -105.2% |
| FY2023 | Dec 31, 2023 | $96.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$20.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$28.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$32.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$25.00K | -256.3% |
| Q2 FY2025 | Jun 30, 2025 | -$24.00K | -700.0% |
| Q1 FY2025 | Mar 31, 2025 | -$2.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $16.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $4.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.00K | – |
See a number that looks wrong?